Home Cart Sign in  
Chemical Structure| 2267329-76-8 Chemical Structure| 2267329-76-8

Structure of EGFR-IN-7
CAS No.: 2267329-76-8

Chemical Structure| 2267329-76-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

TQB3804 is the forth-generation EGFR inhibitor with IC50 values of 7.92nM,0.218nM and 0.16nM for EGFR(WT), EGFR (C797S/T790M/del19) and EGFR (L858R/T790M/C797S), respectively.

Synonyms: TQB3804

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of EGFR-IN-7

CAS No. :2267329-76-8
Formula : C32H41BrN9O2P
M.W : 694.60
SMILES Code : CN1CCN(C2CCN(C3=C(C)C=C(NC4=NC=C(Br)C(NC5=CC=C6N=CC=NC6=C5P(C)(C)=O)=N4)C(OC)=C3)CC2)CC1
Synonyms :
TQB3804
MDL No. :N/A
InChI Key :ZYSKXRAGBGLELB-UHFFFAOYSA-N
Pubchem ID :138911391

Safety of EGFR-IN-7

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Related Pathways of EGFR-IN-7

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Description
EGFR-IN-7 is a highly potent, selective, and orally active inhibitor of EGFR kinase. It exhibits inhibitory activity against both EGFR (WT) and EGFR (mutant C797S/T790M/L858R), with IC50 values of 7.92 nM and 0.218 nM, respectively. EGFR-IN-7 is applicable for research pertaining to various cancers[1].
Target
  • mutant EGFR

    EGFRL858R/T790M, IC50:0.19 nM

    EGFRd746-750/T790M/C797S, IC50:0.26 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04128085 Advanced Malignant Tumors PHASE1 UNKNOWN 2025-10-21 Guangdong Provincial People's ... More >>Hospital, Guangzhou, Guangdong, 510050, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.44mL

0.29mL

0.14mL

7.20mL

1.44mL

0.72mL

14.40mL

2.88mL

1.44mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories